Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 206 | 249 | 159 | 315 | 300 |
| Cost of Goods | 306 | 108 | 64 | 140 | 144 |
| Gross Profit | -100 | 141 | 95 | 175 | 157 |
| Operating Expenses | 4,008 | 1,662 | 2,271 | 9,124 | 4,263 |
| Operating Income | -3,802 | -1,413 | -2,112 | -8,809 | -3,963 |
| Interest Expense | 348 | 969 | 973 | 975 | 975 |
| Other Income | 74,126 | -593 | 0 | 16 | 32 |
| Pre-tax Income | 69,976 | -2,976 | -3,085 | -9,768 | -4,906 |
| Net Income Continuous | 69,976 | -2,976 | -3,085 | -9,768 | -4,906 |
| Net Income Discontinuous | 222 | -143 | -27 | 30 | -24 |
| Minority Interests | 213 | 5 | -14 | -1,607 | -13 |
| Net Income | $69,985 | $-3,124 | $-3,098 | $-8,131 | $-4,917 |
| EPS Basic Total Ops | 645.06 | -30.00 | -30.00 | -82.51 | -48.75 |
| EPS Basic Continuous Ops | 645.06 | -30.00 | -30.00 | -80.99 | -48.75 |
| EPS Basic Discontinuous Ops | 1.56 | -1.40 | -0.26 | -0.16 | -0.24 |
| EPS Diluted Total Ops | 645.06 | -30.00 | -30.00 | -82.51 | -48.75 |
| EPS Diluted Continuous Ops | 645.06 | -30.00 | -30.00 | -80.99 | -48.75 |
| EPS Diluted Discontinuous Ops | 1.56 | -1.40 | -0.26 | -0.16 | -0.24 |
| EBITDA(a) | $-3,620 | $-797 | $-1,925 | $-8,309 | $-3,432 |